Tetrabenazine and Hallucinations aggravated - a phase IV clinical study of FDA data

Summary:

Hallucinations aggravated is reported as a side effect among people who take Tetrabenazine (tetrabenazine), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Ramipril, and have Depression.

The phase IV clinical study analyzes which people have Hallucinations aggravated when taking Tetrabenazine. It is created by eHealthMe based on reports of 1,576 people who have side effects when taking Tetrabenazine from the FDA, and is updated regularly.

What is Tetrabenazine?

Tetrabenazine has active ingredients of tetrabenazine. eHealthMe is studying from 1,580 Tetrabenazine users. Check the latest studies of Tetrabenazine.

What is Hallucinations aggravated?

Hallucinations aggravated (sensations that appear real but are created by your mind) is found to be associated with 1,653 drugs and 558 conditions by eHealthMe. Check the latest studies of Hallucinations aggravated.

On Jul, 28, 2026

1,576 people reported to have side effects when taking Tetrabenazine.
Among them, 43 people (2.73%) have Hallucinations aggravated.

Could Tetrabenazine cause Hallucinations aggravated?

Among these 43 people:

How long have people been on Tetrabenazine when they have Hallucinations aggravated? *

What is the gender of people who have Hallucinations aggravated when taking Tetrabenazine? *

female: 90.24 %
male: 9.76 %

What is the age of people who have Hallucinations aggravated when taking Tetrabenazine? *

What are other drugs people take besides Tetrabenazine? *

Ramipril: 25 people, 58.14%
Fenofibrate: 24 people, 55.81%
Lorazepam: 22 people, 51.16%
Beconase: 21 people, 48.84%
Metoclopramide: 20 people, 46.51%
Mirtazapine: 20 people, 46.51%
Lansoprazole: 13 people, 30.23%
Omeprazole: 11 people, 25.58%
Paroxetine Hydrochloride: 9 people, 20.93%
Atorvastatin Calcium: 6 people, 13.95%

What are other side effects people have besides Hallucinations aggravated? *

Fall: 28 people, 65.12%
Akathisia (a movement disorder characterized by a feeling of inner restlessness): 24 people, 55.81%
Muscle Contractions Involuntary (uncontrolled muscle contraction): 22 people, 51.16%
Eating Disorder: 20 people, 46.51%
Dyskinesia (abnormality or impairment of voluntary movement): 11 people, 25.58%
Tardive Dyskinesia (a disorder that involves involuntary movements): 8 people, 18.60%
Movement - Uncontrolled Or Slow: 6 people, 13.95%
Dizziness: 6 people, 13.95%
Hypophagia (reduced food intake): 6 people, 13.95%
Drowsiness: 5 people, 11.63%

What are the existing conditions these people have? *

Depression: 27 people, 62.79%
Tardive Dyskinesia (a disorder that involves involuntary movements): 10 people, 23.26%
Bipolar Disorder (mood disorder): 4 people, 9.30%
Mania (a state of abnormally elevated or irritable mood): 4 people, 9.30%
Hypersensitivity: 2 people, 4.65%
Stress And Anxiety: 2 people, 4.65%
Muscle Spasms (muscle contraction): 2 people, 4.65%
Cerebral Palsy: 2 people, 4.65%
High Blood Cholesterol: 2 people, 4.65%
Diabetic Gastroparesis (paralysis of the muscles of the stomach caused by diabetes): 1 person, 2.33%

* Approximation only. Some reports may have incomplete information.

Do you take Tetrabenazine and have Hallucinations aggravated?

- Check whether Hallucinations aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tetrabenazine:

Tetrabenazine (1,580 reports)

Browse all side effects of Tetrabenazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hallucinations aggravated:

Hallucinations aggravated (1,654 drugs)

Browse all the conditions that are associated with Hallucinations aggravated:

Hallucinations aggravated (558 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tetrabenazine (the active ingredients of Tetrabenazine) and Tetrabenazine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.